Diverse approaches to the manufacturing of additives! We have successfully developed and launched products globally.
We will introduce our representative formulation technology along with specific examples. The "composite preparation" has successfully developed all four approaches, including single-layer single-group tablets, single-layer two-group tablets, layered tablets, and core tablets / active ingredient coated tablets. We have a proven track record of launching these globally. We respond to all requests related to CMC from the early stages of development to application. Please feel free to contact us when needed. 【Four Approaches】 ■ Single-layer single-group tablets ■ Single-layer two-group tablets ■ Layered tablets ■ Core tablets / active ingredient coated tablets *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.